Citation Information :
Mendoza R, Chiong L. Antibacterial Efficacy of Matricaria recutita Essential Oil against Porphyromonas gingivalis and Prevotella intermedia: In Vitro Study. J Contemp Dent Pract 2023; 24 (8):551-555.
Aim: To evaluate in vitro the antibacterial efficacy of Matricaria recutita (chamomile) essential oil at 50 and 75% against Porphyromonas gingivalis ATCC 33277 and Prevotella intermedia ATCC 25611 at 24 and 48 hours.
Material and methods: The sample consisted of 80 discs and Mueller–Hinton Agar, the medium chosen for the culture. To determine the bacterial sensitivity, discs were placed in each Petri dish with concentrations of essential oil at 50 and 75%, distilled water and 0.12% chlorhexidine. Subsequently, the inhibition halos were measured in millimeters at 24 and 48 hours after culture, with the Kirby–Bauer disk diffusion method.
Results: In groups treated with Porphyromonas gingivalis, measurements at 24 and 48 hours yielded 22.14 ± 2.61 and 22.63 ± 2.67 mm for 0.12% chlorhexidine, 18.90 ± 0.41 and 19.22 ± 0.54 mm for 75% essential oil, and 15.55 ± 0.45 and 15.77 ± 0.46 mm for 50% essential oil, respectively. No statistically significant differences were observed among the groups (p > 0.05).
Conclusion: No significant differences were found between the antibacterial efficacy of 0.12% chlorhexidine and 50 and 75% essential oil of Matricaria recutita on Porphyromonas gingivalis and Prevotella intermedia at 24 and 48 hours.
Clinical significance: The study demonstrates that essential oil derived from Matricaria recutita may effectively combat bacteria associated with periodontal disease. This discovery has the potential to impact dental practice by introducing a natural treatment option. Further research is warranted to fully elucidate the clinical significance and potential applications of this finding.
André Kramer AC, Pivodic A, Hakeberg M, et al. Multilevel analysis of dental caries in Swedish children and adolescents in relation to socioeconomic status. Caries Res 2019;53(1):96–106. DOI: 10.1159/000489570.
Sfreddo CS, Moreira CHC, Nicolau B, et al. Socioeconomic inequalities in oral health-related quality of life in adolescents: a cohort study. Qual Life Res 2019;28(9):2491–500. DOI: 10.1007/s11136-019-02229-2.
Uguru N, Onwujekwe O, Ogu UU, et al. Access to oral health care: A focus on dental caries treatment provision in Enugu Nigeria. BMC Oral Health 2020;20(1):145. DOI: 10.1186/s12903-020-01135-1.
Patini R, Mangino G, Martellacci L, et al. The effect of different antibiotic regimens on bacterial resistance: A systematic review. Antibiotics. 2020;9(1):22. DOI: 10.3390/antibiotics9010022.
Abuzenada BM, Pullishery F, Elnawawy MSA, et al. Complementary and alternative medicines in oral health care: an integrative review. J Pharm Bioallied Sci noviembre de 2021;13(2):892–897. DOI: 10.4103/jpbs.jpbs_92_21.
Milutinovici RA, Chioran D, Buzatu R, et al. Vegetal compounds as sources of prophylactic and therapeutic agents in dentistry. Plants 2021;10(10):1–24. DOI: 10.3390/plants10102148.
Angulo-Bazán Y. Bibliometric indicators of Peruvian scientific output on medicinal plants. Rev Peru Med Exp Salud Publica 2020;37(3):495–503. DOI: 10.17843/rpmesp.2020.373.5234.
Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 2018;89(1):173–182. DOI: 10.1111/jcpe.12946.
Hajishengallis G, Lamont RJ. Polymicrobial communities in periodontal disease: Their quasi-organismal nature and dialogue with the host. Periodontol 2000. 2021;86(1):210–230. DOI: 10.1111/prd.12371.
Wang W, Wang Y, Zou J, et al. The mechanism action of German chamomile (Matricaria recutita L.) in the treatment of eczema: based on dose-effect weight coefficient network pharmacology. Front Pharmacol 2021;12:706836. DOI: 10.3389/fphar.2021.706836.
Blasco-Baque V, Garidou L, Pomié C, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut 2016;66(5):872–885. DOI: 10.1136/gutjnl-2015-309897.
Salamon I, Ibraliu A, Kryvtsova M. Essential oil content and composition of the chamomile inflorescences [Matricaria recutita l.] belonging to Central Albania. Horticulturae. 2023;9(1):47. DOI: 10.3390/horticulturae9010047.
Batista ALA, Diógenes Alves Uchôa Lins R, de Souza Coelho R, et al. Clinical efficacy analysis of the mouth rinsing with pomegranate and chamomile plant extracts in the gingival bleeding reduction. Complement Ther Clin Pract 2014;20(1):93–98. DOI: 10.1016/j.ctcp.2013.08.002.
Agarwal A, Chaudhary B. Clinical and microbiological effects of 1% Matricaria chamomilla mouth rinse on chronic periodontitis: a double-blind randomized placebo controlled trial. J Indian Soc Periodontol 2020;24(4):354–361. DOI:10.4103/jisp.jisp_441_19.
Vahid Afagh H, Saadatmand S, Riahi H, et al. Effects of leached spent mushroom compost [lsmc] on the yield, essential oil composition and antioxidant compounds of German chamomile (Matricaria recutita L.). J Essent Oil-Bearing Plants 2018;21(6):1436–1449. DOI:10.1080/0972060X.2019.1580617.
Ahmad I, Wahab S, Nisar N, et al. Evaluation of antibacterial properties of Matricaria aurea on clinical isolates of periodontitis patients with special reference to red complex bacteria. Saudi Pharm J 2020;28(10):1203–1209. DOI: 10.1016/j.jsps.2020.08.010.
Shirakawa S, Matsushima Y, Kajiyama S, et al. Effects of natural herb-containing dental toothpaste on periodontal pathogenic bacteria and clinical parameters: a randomized clinical trial. J Herb Med 2021;30:100517. 10.1016/j.hermed.2021.100517.
Lins R, Vasconcelos FHP, Leite RB, et al. Clinical evaluation of mouthrinses with extracts of mastic (Schinus terebinthifolius) and Chamomile (Matricaria recutita L.) on bacterial plaque and gingivitis. Rev Bras Plantas Med 2013;15(1):112–120. DOI:10.1590/S1516-05722013000100016.
Zhang Z, Liu D, Liu S, et al. The role of Porphyromonas gingivalis outer membrane vesicles in periodontal disease and related systemic diseases. Front Cell Infect Microbiol 2021;10:585917. DOI: 10.3389/fcimb.2020.585917.